LawyersandSettlements.com Interviews Lead Author On Study Showing Link Between Fluoroquinolone-Based

A year after the US Food and Drug Administration (FDA) addressed the subject of a label change for fluoroquinolones that pose a risk for Peripheral Neuropathy (PN), a new Canadian study suggests the risk for PN among users of fluoroquinolone-based antibiotics is double that of non-users. LawyersandSettlements.com now interviews the lead author of the study, Dr. Mahyar Etminan, PharmD. of the University of British Columbia. Vancouver, BC (PRWEB) September 08, 2014 It was in 2008 that the FDA mandated a black box warning on the prescribing labels of some fluoroquinolone-based antibiotics* wi
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations